Metastat, Revenue Growth Rates (PVSO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Metastat, Inc.  (PVSO)
 

PVSO's Revenue Growth by Quarter and Year

Metastat,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PVSO Revenue (in millions $) FY 2013 FY 2012 FY 2011 FY 2010
4th Quarter February 0.00
3rd Quarter November 0.00
2nd Quarter August 2.56
1st Quarter May 0.00
FY 2.56





PVSO Revenue fourth quarter 2013 Y/Y Growth Comment
Metastat, Inc. in the fourth quarter 2013 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2013, Metastat, Inc. achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Metastat, Inc.' s Revenue meltdown of -100% ranks overall at the positon no. in the fourth quarter 2013.


PVSO Revenue ( Y/Y Growth %) 2013
 2012 2011 2010
4th Quarter February - - - -
3rd Quarter November - - - -
2nd Quarter August - - - -
1st Quarter May - - - -
FY   190.91 % - - -

Financial Statements
Metastat,'s fourth quarter 2013 Revenue $ 0.00 millions PVSO's Income Statement
Metastat,'s fourth quarter 2012 Revenue $ 0.88 millions Quarterly PVSO's Income Statement


PVSO Revenue (Quarter on Quarter Growth %)

 2013
 2012 2011 2010
4th Quarter February - - - -
3rd Quarter November - - - -
2nd Quarter August - - - -
1st Quarter May - - - -
FY (Year on Year)   190.91 % - - -


Back to PVSO Growth rate Comparisons >> Back to PVSO Growth rate Comparisons >>


Revenue fourth quarter 2013 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2013 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2010, 2011, 2012, 2013

Metastat,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PVSO's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PVSO's IV. Quarter Q/Q Revenue Comment


Metastat,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Nov 30 2014)		 12 Months Ending
(Aug 31 2014)		 12 Months Ending
(May 31 2014)		 12 Months Ending
(Feb 28 2014)		 12 Months Ending
(Nov 30 2013)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Nov 30 2014 period, Metastat,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Metastat, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Nov 30 2014 period, Metastat,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Metastat, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PVSO's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Feb 28 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Feb 28 2018
Angiodynamics Inc -2.05%$ -2.046 millions
Biomerica Inc -8.28%$ -8.281 millions
Q Biomed inc -100.00%$ -99.995 millions


About Metastat, Revenue Growth Rates (PVSO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.